Ethics/Regulatory

MHRA, BIA call for earlier access to medicines in the U.K.

Monday, November 18, 2013 01:39 PM

Following the publication of the report on innovation in the regulation of healthcare by the Medicines and Healthcare Products Regulatory Agency (MHRA), the BioIndustry Association (BIA) urges the U.K. government to implement a properly funded and reimbursed Earlier Access to medicines Scheme (EAS), which the group makes its number one recommendation.

More... »

WIRB Copernicus Group

Pfizer responds to U.K. pharma pricing deal

Wednesday, November 6, 2013 12:43 PM

Pfizer released a statement calling the new Pharmaceutical Price Regulation Scheme (PPRS), agreed to by the U.K. government and industry, a missed opportunity for British patients, the U.K. economy and industry.

More... »


FDA approves first medicine with Breakthrough Therapy designation

Monday, November 4, 2013 01:35 PM

Genentech, a member of the Roche Group, has announced that the FDA approved Gazyva (obinutuzumab), also known as GA101, in combination with chlorambucil chemotherapy for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL).

More... »

FDA takes two actions on drug shortages

Friday, November 1, 2013 11:14 AM

The FDA is taking two actions to further enhance its ongoing efforts to prevent and resolve drug shortages, a significant public health threat that can delay, and in some cases even deny, critical care for patients. Following the President’s 2011 Executive Order to reduce drug shortages, the number of new shortages in 2012 fell to 117, down from 251 in 2011. 

More... »

NHS fears changing data protection rules could erode quality of research in U.K.

Friday, October 25, 2013 11:48 AM

The NHS European office and the Royal College of Physicians have warned a new Europe-wide law on data protection could have a negative impact on healthcare provision and erode the quality and effectiveness of health research in the U.K.

More... »

FDA awards 15 grants to stimulate drug, device development for rare diseases

Wednesday, October 23, 2013 02:36 PM

The FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.

More... »

Article: Change common rule to increase minority voices in research

Monday, October 21, 2013 02:08 PM

An article to be published in the American Journal of Public Health recommends changing the federal regulations that govern research oversight to address continued underrepresentation of minorities in research studies.

More... »

Sanofi, Merck participate in pilot for rapid European health technology assessment

Friday, October 18, 2013 11:06 AM

Sanofi Pasteur MSD is the first vaccine company to have successfully participated in a pilot testing a new rapid relative effectiveness assessment of health technologies in Europe.

More... »

FDA staff returns to work

Friday, October 18, 2013 09:02 AM

A message on the FDA website from Health and Human Service secretary Katheleen Sebelius thanked readers for their patience throughout the lapse in Federal funding. She said, “The uncertainty of the past few weeks has created many difficult situations, and the shutdown has imposed hardships on many employees as well as the public we serve.”

More... »

Health advocates react to California Gov.’s rejection of patient access to biosimilars bill

Monday, October 14, 2013 02:19 PM

Supporters of SB 598 are reacting with disappointment over California Gov. Jerry Brown’s veto of legislation that would have made the necessary updates to state regulations in anticipation of FDA approval of biosimilar medicines. SB 598 received overwhelming bipartisan approval throughout the legislative process, passing 176-13 in five committees and three floor votes in the Assembly and Senate.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs